Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

More documents

Recommendations

Info

(1995): Cortes JE+, J Clin Oncol 13, 2643 Mucosal Mucositis (2003): Suzuki M+, Jpn J Clin Oncol 33(6), 297 (2002): Marx G+, Br J Cancer 87(8), 846 (with ifosfamide) (2002): Rein DT+, Gynecol Oncol 87(1), 98 (with carboplatin) Stomatitis (5–42%) (2007): Tashiro H+, Gan To Kagaku Ryoho 34(3), 393 (with cyclophosphamide) (25%) (2006): Izquierdo MA+, Eur J Cancer 42(12), 1789 (with paclitaxel) (2005): G Oumlker E+, Neth J Med 63(9), 364 (2003): Han JY+, Cancer 98(9), 1918 (33%) (with capecitabine) (2003): Qin YK+, Ai Zheng 22(4), 415 (2002): Bonneterre J+, Br J Cancer 87(11), 1210 (5%) (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) (1996): Edmonson JH+, Am J Clin Oncon 19, 574 Hair Hair – alopecia (80%) (2007): Tashiro H+, Gan To Kagaku Ryoho 34(3), 393 (with cyclophosphamide) (100%) (2007): Tashiro H+, Gan To Kagaku Ryoho 34(3), 453 (100%) (2004): Gridelli C+, Br J Cancer 91(12), 1996 (2003): Qin YK+, Ai Zheng 22(4), 415 (2003): Yoshida K+, Gan To Kagaku Ryoho. 30(12), 1927 (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) (2002): Koukourakis MI+, Anticancer Res 22(4), 2491 (2002): Rein DT+, Gynecol Oncol 87(1), 98 (with carboplatin) (1995): Lemenager M+, Lancet 346, 371 Nails Nails – Beau’s lines (transverse nail bands) (2001): Camidge DR+, Lancet Oncol 2(6), 342 (1999): Correia O+, Dermatology 198, 288 Nails – changes (sic) (2003): Kuroi K+, Breast Cancer 10(1), 10 (2003): Rafi L+, Eur J Dermatol 13(6), 610 (severe) (2003): Yoshida K+, Gan To Kagaku Ryoho. 30(12), 1927 (2002): Pavithran K+, Br J Dermatol 146(4), 709 (2001): Kuroi K+, Gan To Kagaku Ryoho (Japanese) 28(6), 797 (2001): Wasner G+, Lancet 357(9260), 910 Nails – discoloration (2003): Mourad YA+, Dermatol Online J 9(3), 15 (2002): Nicolopoulos J+, Australas J Dermatol 43(4), 293 Nails – dystrophy (2006): Alexandrescu DT+, Int J Dermatol 45(11), 1334 (with Trastuzumab) Nails – hyponychial dermatitis (2003): Chen GY+, Br J Dermatol 148, 1071 (with capecitabine) Nails – loss (2004): Mackey JR+, Clin Breast Cancer 5(4), 287 (45%) (with capecitabine) (2003): Maisano R+, Anticancer Res 23(2C), 1923 (2003): Mourad YA+, Dermatol Online J 9(3), 15 Nails – onycholysis (2003): Mourad YA+, Dermatol Online J 9(3), 15 (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) (2002): Nicolopoulos J+, Australas J Dermatol 43(4), 293 (1999): Correia O+, Dermatology 198, 288 (1998): Obermair A+, Ann Oncol 9, 230 (1996): Dreyfuss AL+, J Clin Oncol 14, 1672 (1996): Trudeau ME, Semin Oncol 22, 17 (1995): Zimmerman GC+, Arch Dermatol 131, 202 Nails – paronychia (2002): Nicolopoulos J+, Australas J Dermatol 43(4), 293 (1999): Correia O+, Dermatology 198, 288 (painful) Nails – pigmentation (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) DOCETAXEL 187 (1999): Correia O+, Dermatology 198, 288 (orange discoloration) (1998): Jacob CI+, Arch Dermatol 134, 1167 (nail bed dyschromia) Nails – subungual abscess (2002): Nicolopoulos J+, Australas J Dermatol 43(4), 293 (2000): Vanhooteghem O+, Br J Dermatol 143, 462 Nails – subungual hemorrhages (2002): Nicolopoulos J+, Australas J Dermatol 43(4), 293 (1999): Correia O+, Dermatology 198, 288 Nails – subungual hyperkeratosis (1999): Correia O+, Dermatology 198, 288 Nails – transverse superficial loss of nail plate (1999): Correia O+, Dermatology 198, 288 (1997): Llombart-Cussac A+, Arch Dermatol 133, 1466 Eyes Epiphora (2007): Tinker AV+, Gynecol Oncol 104(3), 647 (8%) (2006): Esmaeli B+, J Clin Oncol 24(22), 3619 (64%) (2006): Kintzel PE+, Pharmacotherapy 26(6), 853 (2006): Tsalic M+, Med Oncol 23(1), 57 (33%) (2005): Esmaeli B, Clin Breast Cancer 5(6), 455 (2003): Kuroi K+, Breast Cancer 10(1), 10 (2003): Maisano R+, Anticancer Res 23(2C), 1923 Other Abdominal pain (2003): Viret F+, Pancreas 27(3), 214 Anaphylactoid reactions/Anaphylaxis (2007): Gunthert AR+, Gynecol Oncol 104(1), 86 Application-site fixed eruption (1995): Zimmerman GC+, Arch Dermatol 131, 202 Cough (2004): Gridelli C+, Br J Cancer 91(12), 1996 Death (2006): Laber DA+, Am J Clin Oncol 29(4), 389 (4%) (2003): Han JY+, Cancer 98(9), 1918 (2 cases) (with capecitabine) (2002): Morris MJ+, Urology 60(6), 1111 Extravasation (2005): Barcelo R+, Arch Dermatol 141(10), 1326 Fever (2006): Yip AY+, Breast Cancer 13(2), 192 (19%) Fibrosis (2000): Cleveland MG+, Cancer 88, 1078 (generalized) Hypersensitivity (1–28%) (2005): Feldweg AM+, Gynecol Oncol 96(3), 824 (2004): Furugen Y+, Gan To Kagaku Ryoho 31(8), 1205 (25%) (with carboplatin) (2002): Denman JP+, J Clin Oncol 20(11), 2760 (previous hypersensitivity to paclitaxel) (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) (1996): Hudis CA+, J Clin Oncol 14, 58 (1995): Bedikian AY+, J Clin OncoI 13, 2895 (1993): Schrijvers D+, Ann Oncol 4, 610 (28%) Inappropriate secretion of antidiuretic hormone (SIADH) (2000): Langer-Nitsche C+, Acta Oncol 39(8), 1001 Infections (2002): Bonneterre J+, Br J Cancer 87(11), 1210 (2%) (2002): Koukourakis MI+, Anticancer Res 22(4), 2491 (2002): Souglakos J+, Cancer 95(6), 1326 (11.7%) Injection-site dermatitis (2002): Hirai K+, Gynecol Obstet Invest 53(2), 118 Injection-site erythema (2002): Hirai K+, Gynecol Obstet Invest 53(2), 118 (1995): Zimmerman GC+, Arch Dermatol 131, 202 Injection-site exanthems (2002): Hirai K+, Gynecol Obstet Invest 53(2), 118
188 DOCETAXEL Injection-site extravasation (2000): Raley J+, Gynecol Oncol 78, 259 (1995): Zimmerman GC+, Arch Dermatol 131, 202 Injection-site pigmentation (2005): Aydogan I+, JEurAcadDermVen19, 345 (supravenous, serpentine) (2000): Schrijvers D+, Br J Dermatol 142, 1069 (1995): Zimmerman GC+, Arch Dermatol 131, 202 Injection-site reactions (2002): Eich D+, Am J Clin Oncol 25(6), 599 (passim) Myalgia/Myositis/Myopathy/Myotoxicity (>10%) (2006): Izquierdo MA+, Eur J Cancer 42(12), 1789 (with paclitaxel) (2005): Hughes BG+, Intern Med J 35(6), 369 (2003): Qin YK+, Ai Zheng 22(4), 415 Neurotoxicity (2006): Izquierdo MA+, Eur J Cancer 42(12), 1789 (with paclitaxel) (2006): Lee JJ+, J Clin Oncol 24(10), 1633 (2005): Wampler MA+, Clin J Oncol Nurs 9(2), 189 (2004): Furugen Y+, Gan To Kagaku Ryoho 31(8), 1205 (6%) (with carboplatin) (1998): Hainsworth JD+, J Clin Oncol 16(6), 2164 Pain (2004): Gridelli C+, Br J Cancer 91(12), 1996 (2002): Paciucci PA+, Anticancer Drugs 13(8), 791 Thrombosis (2006): Laber DA+, Am J Clin Oncol 29(4), 389 (8%) DOCOSANOL Synonyms: Behenyl Alcohol; n-Docosanol Trade name: Abreva (GSK) Indications: Herpes simplex (labialis) Category: Antiviral, topical Half-life: N/A Clinically important, potentially hazardous interactions with: None Skin Irritation (sic) (local) DOCUSATE Reactions Trade names: Colase (Purdue); Coloxyl; Dialose; Diocto; Disonate; DOK; Doxate-S; Doxinate; Hisof; Jamylene; Lambanol; Mollax; Peri-Colase (Purdue); Regulex; Regutol; Selax; SoFlax; Softon; Sulfalax; Surfak (Pfizer) Indications: Constipation Category: Stimulant laxative Half-life: N/A Onset of action: 12–72 hours Reactions Skin Dermatitis (1998): Lee AY+, Contact Dermatitis 38, 355 Diaphoresis Exanthems (1%) Rash (sic) DOFETILIDE Trade name: Tikosyn (Pfizer) Indications: Conversion of atrial fibrillation and atrial flutter to normal sinus rhythm Category: Antiarrhythmic class III Half-life: 10 hours Clinically important, potentially hazardous interactions with: atazanavir, chlorpromazine, cimetidine, co-trimoxazole, fluphenazine, ketoconazole, medroxyprogesterone, megestrol, mesoridazine, phenothiazines, prochlorperazine, progestins, promethazine, thioridazine, trifluoperazine, trimethoprim, verapamil Skin Angioedema (2%) Edema Peripheral edema (>2%) Rash (sic) (3%) DOLASETRON Reactions Trade name: Anzemet (Sanofi-Aventis) Indications: Prevention of nausea and vomiting Category: 5-HT3 antagonist; Serotonin type 3 receptor antagonist Half-life: 7.3 hours Reactions Skin Diaphoresis Edema Facial edema Peripheral edema Pruritus Purpura Rash (sic) Urticaria Eyes Ocular pigmentation Other Anaphylactoid reactions/Anaphylaxis Chills (>2%) Hot flashes (1997): Keung AC+, Biopharm Drug Dispos 18(4), 361 Myalgia/Myositis/Myopathy/Myotoxicity Thrombophlebitis
Page 1:
Litt’s Drug Eruption rEfErEncE Ma
Page 6 and 7:
CONTENTS Introduction vii Index of
Page 8 and 9:
INTRODUCTION Any drug can cause any
Page 10:
A plus sign (+) after the authors n
Page 13 and 14:
INDEX OF GENERIC AND TRADE NAMES Ad
Page 15 and 16:
INDEX OF GENERIC AND TRADE NAMES am
Page 17 and 18:
INDEX OF GENERIC AND TRADE NAMES as
Page 19 and 20:
INDEX OF GENERIC AND TRADE NAMES Be
Page 21 and 22:
INDEX OF GENERIC AND TRADE NAMES ca
Page 23 and 24:
INDEX OF GENERIC AND TRADE NAMES ci
Page 25 and 26:
INDEX OF GENERIC AND TRADE NAMES Cy
Page 27 and 28:
INDEX OF GENERIC AND TRADE NAMES Di
Page 29 and 30:
INDEX OF GENERIC AND TRADE NAMES Du
Page 31 and 32:
INDEX OF GENERIC AND TRADE NAMES Et
Page 33 and 34:
INDEX OF GENERIC AND TRADE NAMES FU
Page 35 and 36:
INDEX OF GENERIC AND TRADE NAMES Hi
Page 37 and 38:
INDEX OF GENERIC AND TRADE NAMES Is
Page 39 and 40:
INDEX OF GENERIC AND TRADE NAMES Le
Page 41 and 42:
INDEX OF GENERIC AND TRADE NAMES Me
Page 43 and 44:
INDEX OF GENERIC AND TRADE NAMES Mo
Page 45 and 46:
INDEX OF GENERIC AND TRADE NAMES Ni
Page 47 and 48:
INDEX OF GENERIC AND TRADE NAMES Op
Page 49 and 50:
INDEX OF GENERIC AND TRADE NAMES pe
Page 51 and 52:
INDEX OF GENERIC AND TRADE NAMES Pr
Page 53 and 54:
INDEX OF GENERIC AND TRADE NAMES Re
Page 55 and 56:
INDEX OF GENERIC AND TRADE NAMES Si
Page 57 and 58:
INDEX OF GENERIC AND TRADE NAMES Sy
Page 59 and 60:
INDEX OF GENERIC AND TRADE NAMES to
Page 61 and 62:
INDEX OF GENERIC AND TRADE NAMES Ur
Page 63 and 64:
INDEX OF GENERIC AND TRADE NAMES Xo
Page 65 and 66:
INDEX OF HERBALS Cola acuminata caf
Page 67 and 68:
INDEX OF HERBS Smilax regelii sarsa
Page 69 and 70:
MAIN CLASSES OF DRUGS ACE inhibitor
Page 71 and 72:
Antiplatelet abciximab aspirin cilo
Page 73 and 74:
MAIN CLASSES OF DRUGS Histamine H1
Page 76 and 77:
ABACAVIR Trade names: Trizivir (GSK
Page 78 and 79:
Xerostomia (2%) Hair Hair - alopeci
Page 80 and 81:
(2006): Santoro D+, Clin Nephrol 66
Page 82 and 83:
Exanthems (2-25%) (1999): Katz HI+,
Page 84 and 85:
ADALIMUMAB Synonym: D2E7 Trade name
Page 86 and 87:
ALBENDAZOLE Trade names: ABZ; Alben
Page 88 and 89:
(2003): Chodorowska G+, Ann Univ Ma
Page 90 and 91:
ALFENTANIL Trade names: Alfenta (Ak
Page 92 and 93:
Lupus erythematosus (1980): Condemi
Page 94 and 95:
Other Abdominal pain (2005): Turgeo
Page 96 and 97:
(1982): van Ketel WG, Contact Derma
Page 98 and 99:
Exanthems Photosensitivity (1984):
Page 100 and 101:
(1980): Lawyer CH+, J Allergy Clin
Page 102 and 103:
Purpura (2%) (1983): Fogoros RN+, C
Page 104 and 105:
(2006): Piller LB+, J Clin Hyperten
Page 106 and 107:
(2006): Gonzalez-Delgado P+, Allerg
Page 108 and 109:
Chills (2004): Martino R, Curr Med
Page 110 and 111:
AMPRENAVIR* Trade name: Agenerase (
Page 112 and 113:
(2001): Ahrendt DM, Am Fam Physicia
Page 114 and 115:
(1999): Ellenberg SS, Center for Bi
Page 116 and 117:
(1996): Martinelli L+, Ann Thorac S
Page 118 and 119:
(2003): Uede K+, Br J Dermatol 149(
Page 120 and 121:
ARTEMISIA Scientific names: Artemis
Page 122 and 123:
ASPIRIN Synonyms: acetylsalicylic a
Page 124 and 125:
ATAZANAVIR Trade name: Reyataz (Bri
Page 126 and 127:
(1999): Oakley A, Hamilton, New Zea
Page 128 and 129:
(2002): Robenshtok E+, Isr Med Asso
Page 130 and 131:
Scleroderma (1993): Choy E+, Br J R
Page 132 and 133:
(1997): Epstein ME+, JAmAcadDermato
Page 134 and 135:
Hair Hair - hypertrichosis (3-10%)
Page 136 and 137:
(1997): Banac S+, Acta Paediatr 86(
Page 138 and 139:
BENZALKONIUM Synonyms: parasterol;
Page 140 and 141:
(2002): Gruson LM+, Arch Pediatr Ad
Page 142 and 143:
(2000): Bedikian AY+, Oncol Rep 7,
Page 144 and 145:
BISMUTH Trade names: Bismatrol; Bis
Page 146 and 147:
BLEOMYCIN Synonyms: bleo; BLM Trade
Page 148 and 149:
BLOODROOT Scientific name: Sanguina
Page 150 and 151:
Punctate keratitis (2004): Northing
Page 152 and 153:
BROMFENAC Trade name: Xibrom (ISTA
Page 154 and 155:
Erythema multiforme (
Page 156 and 157:
Myalgia/Myositis/Myopathy/Myotoxici
Page 158 and 159:
(1989): Ackerman WE+, Can J Anaesth
Page 160 and 161:
CALFACTANT Trade name: Infasurf (Fo
Page 162 and 163:
CAPSICUM Scientific names: Capsicum
Page 164 and 165:
Lupus erythematosus (2002): Ratliff
Page 166 and 167:
Corneal edema Eyelid twitching Kera
Page 168 and 169:
Stevens-Johnson syndrome (1-10%) (2
Page 170 and 171:
Porphyria variegata (2001): Grieco
Page 172 and 173:
(1983): Rollings HE+, Curr Ther Res
Page 174 and 175:
Dermatitis (1986): Hirata M+, Kokyu
Page 176 and 177:
Other Anaphylactoid reactions/Anaph
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Candidiasis (
Page 184 and 185:
Herpes zoster (
Page 186 and 187:
Hypersensitivity Injection-site pai
Page 188 and 189:
Other Abdominal pain (25%) Anaphyla
Page 190 and 191:
CHLORAMBUCIL Trade names: Chloramin
Page 192 and 193:
(1992): Ramselaar CG+, Br J Urol 70
Page 194 and 195:
(1997): Selvaag E, Ann Trop Pediatr
Page 196 and 197:
(1989): Rosen C, Semin Dermatol 8,
Page 198 and 199:
CHOLESTYRAMINE Trade names: Chol-Le
Page 200 and 201:
CIMETIDINE Trade names: Apo-Cimetid
Page 202 and 203:
(2000): Sharobeem KM+, J Cardiovasc
Page 204 and 205:
(1997): Carrasco JM+, Ann Pharmacot
Page 206 and 207:
CITALOPRAM Synonym: nitalapram Trad
Page 208 and 209:
CLEMASTINE Trade names: Aller-Eze;
Page 210 and 211:
Other Hypersensitivity (2002): Somm
Page 212 and 213: CLOMIPRAMINE Trade names: Anafranil
Page 214 and 215: CLOPIDOGREL Trade name: Plavix (Bri
Page 216 and 217: Eczema (
Page 218 and 219: (1997): Thaler D, Monona, WI (from
Page 220 and 221: COCOA Scientific names: Theobroma c
Page 222 and 223: COLESEVELAM Trade name: Welchol (Sa
Page 224 and 225: CORDYCEPS Scientific name: Cordycep
Page 226 and 227: CYCLAMATE Trade name: Sucaryl (Abbo
Page 228 and 229: Inappropriate secretion of antidiur
Page 230 and 231: (1996): Cox NH, Clin Exp Dermatol 2
Page 232 and 233: (2007): Lim AK+, Intern Med J 37(1)
Page 234 and 235: (1989): Kerker BJ+, Semin Dermatol
Page 236 and 237: Pruritus (1-10%) Rash (sic) (1-10%)
Page 238 and 239: (1988): Tham SN+, Singapore Med J 2
Page 240 and 241: DASATINIB Synonym: BMS354825 Trade
Page 242 and 243: Other Anaphylactoid reactions/Anaph
Page 244 and 245: (1980): Miescher PA+, Clin Haematol
Page 246 and 247: (1985): Job JC+, Arch Fr Pediatr 42
Page 248 and 249: DEXTROMETHORPHAN Trade names: Balmi
Page 250 and 251: Erythema nodosum (
Page 252 and 253: Mucosal Oral ulceration Hair Hair -
Page 254 and 255: (1987): Masden JJ+, Curr Ther Res 4
Page 256 and 257: (1998): Knowles S+, JAmAcadDermatol
Page 258 and 259: Epiphora Other Abdominal pain Fever
Page 260 and 261: DISOPYRAMIDE Trade names: Dimodan;
Page 264 and 265: DOMPERIDONE Trade names: Evoxin; Mo
Page 266 and 267: DOXAPRAM Trade name: Dopram (Baxter
Page 268 and 269: (1989): Jones AP+, Br J Cancer 59,
Page 270 and 271: (1992): Bennett MJ, JRArmyMedCorps1
Page 272 and 273: ECHINACEA Scientific names: Echinac
Page 274 and 275: Hot flashes (
Page 276 and 277: Pemphigus vegetans (1994): Bastiaen
Page 278 and 279: Stevens-Johnson syndrome (
Page 280 and 281: Ocular pruritus (1-10%) Other Cough
Page 282 and 283: (2002): Bohm M+, Drug Saf 25(8), 59
Page 284 and 285: Pustules (1993): Manu Shah R+, Eur
Page 286 and 287: ESTAZOLAM Trade names: Domnamid; Es
Page 288 and 289: Allergic reactions (sic) Cellulitis
Page 290 and 291: Exanthems Photosensitivity Purpura
Page 292 and 293: Other Anticonvulsant hypersensitivi
Page 294 and 295: ETORICOXIB Trade names: Algix; Arco
Page 296 and 297: Purpura (1996): Kallal SM+, West J
Page 298 and 299: (1980): Couzigou P+, Therapie 35(3)
Page 300 and 301: FINASTERIDE Trade names: Pro-Cure;
Page 302 and 303: (1991): Abbott M+, Lancet 2, 633 Bu
Page 304 and 305: FLUOCINOLONE Trade names: Capex (Ga
Page 306 and 307: (2003): Salim A+, Br J Dermatol 148
Page 308 and 309: Erythema multiforme (1985): Wernick
Page 310 and 311: Injection-site reactions Rhabdomyol
Page 312 and 313:
Toxic epidermal necrolysis Urticari
Page 314 and 315:
Reactions Skin Angioedema Erythema
Page 316 and 317:
Reactions Skin Acne (
Page 318 and 319:
Thrombophlebitis *Note: Furosemide
Page 320 and 321:
GANCICLOVIR Trade names: Cymevan; C
Page 322 and 323:
(2002): Baselga J+, J Clin Oncol 20
Page 324 and 325:
(2003): D’Alessandro V+, Clin Ter
Page 326 and 327:
(1996): Merlob P+, Cutis 57, 429 (n
Page 328 and 329:
Hair Hair - alopecia (>2%) Nails Na
Page 330 and 331:
GLYBURIDE Synonyms: glibenclamide;
Page 332 and 333:
(1982): Bailin PL+, Clin Rheum Dis
Page 334 and 335:
Acne (1996): Lee PK+, JAmAcadDermat
Page 336 and 337:
(2006): Bonkovsky HL, AnnInternMed1
Page 338 and 339:
Peripheral edema (>10%) Purpura Urt
Page 340 and 341:
(1984): Binder RL+, J Clin Psychiat
Page 342 and 343:
HEPARIN Trade names: Calcilean; Cal
Page 344 and 345:
(1990): Rogerson SJ+, BMJ 301, 345
Page 346 and 347:
(1991): Vitris M+, Dakar Med 36(1),
Page 348 and 349:
Page 350 and 351:
Exanthems Exfoliative dermatitis Fi
Page 352 and 353:
HYDROMORPHONE Trade names: Dilaudid
Page 354 and 355:
(1994): Perrot JL+, Ann Dermatol Ve
Page 356 and 357:
Edema (
Page 358 and 359:
(1994): Halpern SM, Arch Dermatol 1
Page 360 and 361:
Mucosal Oral lesions Sialorrhea (
Page 362 and 363:
IMIGLUCERASE Trade name: Cerezyme (
Page 364 and 365:
(2001): Fife KH+, Sex Transm Dis 28
Page 366 and 367:
Herpes simplex (
Page 368 and 369:
(2004): Scheinfeld N, J Drugs Derma
Page 370 and 371:
(2000): Poole PJ+, Cochrane Databas
Page 372 and 373:
Injection-site pain (2006): Moyes V
Page 374 and 375:
(2002): Tothova E+, Neoplasma 49(2)
Page 376 and 377:
(1995): Shinohara K, NEnglJMed333,
Page 378 and 379:
IOPROMIDE Trade name: Ultravist (Be
Page 380 and 381:
ISOCARBOXAZID Trade names: Enerzer;
Page 382 and 383:
ISOSORBIDE Trade name: Ismotic Indi
Page 384 and 385:
Nails Nails - brittle (2001): Önde
Page 386 and 387:
Serum sickness (1998): Park H+, Ann
Page 388 and 389:
(2001): Burstal R+, Anaesth Intensi
Page 390 and 391:
Pruritus (1-10%) Psoriasis (1992):
Page 392 and 393:
LAMIVUDINE Synonym: 3TC Trade names
Page 394 and 395:
(2006): Fix OK+, Clin Gastroenterol
Page 396 and 397:
Eyelashes - ptosis (2005): Casson R
Page 398 and 399:
LETROZOLE Trade name: Femara (Novar
Page 400 and 401:
Other Abdominal pain (2003): Cramer
Page 402 and 403:
Photosensitivity (
Page 404 and 405:
(2002): Kalin JR+, JForensicSci47(5
Page 406 and 407:
(2002): Serratrice J+, Am J Ophthal
Page 408 and 409:
(1981): Hess EV, Arthritis Rheum 24
Page 410 and 411:
Purpura (
Page 412 and 413:
Reactions Skin Angioedema (
Page 414 and 415:
Other Abdominal pain (7%) Cough (1%
Page 416 and 417:
Reactions Skin Acne (1998): Wollina
Page 418 and 419:
(1983): Nusbaum BP+, Arch Dermatol
Page 420 and 421:
(1997): O’Reilly FM+, American Ac
Page 422 and 423:
MEMANTINE Trade names: Akatinol; Ax
Page 424 and 425:
MERCAPTOPURINE Synonyms: 6-mercapto
Page 426 and 427:
(1998): Leal G, Fortaleza, Brazil (
Page 428 and 429:
(2002): Caplehorn JR+, Aust N Z J P
Page 430 and 431:
(1995): Vogt T+, Br J Dermatol 133,
Page 432 and 433:
Mucosal Aphthous stomatitis (2003):
Page 434 and 435:
(1987): Norris PG+, Clin Exp Dermat
Page 436 and 437:
(1998): Corazza M+, Contact Dermati
Page 438 and 439:
METOCLOPRAMIDE Trade names: Apo-Met
Page 440 and 441:
Oral ulceration Stomatitis (1987):
Page 442 and 443:
Reactions Skin Erythema multiforme
Page 444 and 445:
(1996): Carrington PR, Little Rock,
Page 446 and 447:
(2003): Abe M+, Intern Med 42(1), 4
Page 448 and 449:
Other Abdominal pain (2006): Preutt
Page 450 and 451:
Erythema multiforme Exanthems (9-16
Page 452 and 453:
Page 454 and 455:
MUPIROCIN* Trade names: Bactoderm;
Page 456 and 457:
Mucosal Gingivitis (
Page 458 and 459:
(1981): Wolf A, ZHautkr(German) 56,
Page 460 and 461:
(1984): Stern RS+, JAMA 252, 1433 V
Page 462 and 463:
Hair Hair - alopecia (
Page 464 and 465:
NEVIRAPINE Trade name: Viramune (Bo
Page 466 and 467:
(1982): Grunwald Z, Drug Intell Cli
Page 468 and 469:
Urticaria (
Page 470 and 471:
(2000): Rodrigues de Oliveira J+, G
Page 472 and 473:
(2007): Koulaouzidis A+, Ann Hepato
Page 474 and 475:
Vulvovaginal candidiasis (2002): Me
Page 476 and 477:
Mucosal Oral mucosal eruption (1987
Page 478 and 479:
Mucosal Tongue edema Other Anaphyla
Page 480 and 481:
Chills (5-10%) Hypersensitivity (
Page 482 and 483:
OXACILLIN Trade names: Bactocill; B
Page 484 and 485:
Page 486 and 487:
OXYMORPHONE Synonym: 14-hydroxy-dih
Page 488 and 489:
(2001): Robinson JB+, Gynecol Oncol
Page 490 and 491:
PANCRELIPASE Trade names: Cotazym (
Page 492 and 493:
Exanthems Fixed eruption (1994): Ki
Page 494 and 495:
(2006): Bettoli V+, Acta Derm Vener
Page 496 and 497:
Reactions Skin Adverse effects (sic
Page 498 and 499:
(1981): Hashimoto K+, JAmAcadDermat
Page 500 and 501:
Hypersensitivity (1999): Hsu HL+, T
Page 502 and 503:
Injection-site calcification (1991)
Page 504 and 505:
PEPPERMINT Scientific name: Mentha
Page 506 and 507:
(1995): Magro CM+, JAmAcadDermatol3
Page 508 and 509:
(1993): Leenutaphong V+, Int J Derm
Page 510 and 511:
PHENYLEPHRINE Trade names: Dionephr
Page 512 and 513:
(1991): Kleier RS, Arch Dermatol 12
Page 514 and 515:
Lymphoproliferative disease (1992):
Page 516 and 517:
(2006): Andersen KE+, Contact Derma
Page 518 and 519:
Oral candidiasis Stomatodynia Vagin
Page 520 and 521:
Reactions Skin Exanthems Petechiae
Page 522 and 523:
Reactions Skin Acne (1-10%) Angioed
Page 524 and 525:
Pruritus (
Page 526 and 527:
PREDNISONE Trade names: Deltasone (
Page 528 and 529:
Other Anticonvulsant hypersensitivi
Page 530 and 531:
Xerosis Mucosal Lip ulceration (198
Page 532 and 533:
(1982): Gall H+, Derm Beruf Umwelt
Page 534 and 535:
(2006): Barkin RL+, Am J Ther 13(6)
Page 536 and 537:
PROTAMINE SULFATE Indications: Hepa
Page 538 and 539:
(1987): Shelley WB+, JAmAcadDermato
Page 540 and 541:
Hypersensitivity Myalgia/Myositis/M
Page 542 and 543:
(1999): Drayton G, Los Angeles, CA
Page 544 and 545:
(1986): Bigby M+, JAMA 256, 3358 (1
Page 546 and 547:
Nails Nails - photo-onycholysis (19
Page 548 and 549:
Hair Hair - alopecia (1-10%) Other
Page 550 and 551:
RASBURICASE Trade names: Elitek (Sa
Page 552 and 553:
RETEPLASE Synonyms: recombinant pla
Page 554 and 555:
Other Inappropriate secretion of an
Page 556 and 557:
Tongue pigmentation Vulvovaginal ca
Page 558 and 559:
Reactions Skin Acne (
Page 560 and 561:
RIZATRIPTAN Synonym: MK462 Trade na
Page 562 and 563:
Glossitis (1%) Stomatitis (
Page 564 and 565:
(1995): Brandstatter G+, Clin Ther
Page 566 and 567:
Mucosal Cheilitis (
Page 568 and 569:
SELENIUM Trade names: Bio-Active Se
Page 570 and 571:
Mucosal Aphthous stomatitis (
Page 572 and 573:
(2004): Vasconcelos OM+, Muscle Ner
Page 574 and 575:
(2005): Mahe E+, Transplantation 79
Page 576 and 577:
SOLIFENACIN Trade name: Vesicare (G
Page 578 and 579:
Urticaria (
Page 580 and 581:
Pruritus (1997): Golsch S+, Hautarz
Page 582 and 583:
Glossitis (2%) Oral mucosal eruptio
Page 584 and 585:
Reactions Skin Allergic reactions (
Page 586 and 587:
(1995): Hertl M+, Br J Dermatol 132
Page 588 and 589:
(1992): Bodokh I+, Presse Med (Fren
Page 590 and 591:
SULFISOXAZOLE* Trade names: Isoxazi
Page 592 and 593:
(1984): Stern RS+, JAMA 252, 1433 J
Page 594 and 595:
TACROLIMUS Synonym: FK506 Trade nam
Page 596 and 597:
(2005): Fumal I+, Dermatology 210(3
Page 598 and 599:
(2000): Ernst E+, Forsch Komplement
Page 600 and 601:
Page 602 and 603:
Reactions Skin Diaphoresis (>1%) Ed
Page 604 and 605:
Mucosal Oral ulceration (1987): Hig
Page 606 and 607:
TETRACYCLINE Trade names: Apo-Tetra
Page 608 and 609:
Xerosis (2002): Bariol C+, J Gastro
Page 610 and 611:
Eyes Conjunctivitis (allergic conta
Page 612 and 613:
Page 614 and 615:
(2000): Chemnitz JM+, Med Klin (Ger
Page 616 and 617:
Note: Cutaneous side-effects of bet
Page 618 and 619:
Other Cough (0.8%) Fever (4.6%) Hep
Page 620 and 621:
TOLAZAMIDE* Trade names: Diabewas;
Page 622 and 623:
Reactions Skin Erythema (1.9%) Fung
Page 624 and 625:
TOSITUMOMAB & IODINE 131 Trade name
Page 626 and 627:
(2001): Vogel CL+, Oncology 61, 37
Page 628 and 629:
(1997): Gilchrest BA, JAmAcadDermat
Page 630 and 631:
Erythema (1999): Alexiou C+, Laryng
Page 632 and 633:
*Note: Trichlormethiazide is a sulf
Page 634 and 635:
TRIMETHOPRIM* Trade names: Abaprim;
Page 636 and 637:
Myalgia/Myositis/Myopathy/Myotoxici
Page 638 and 639:
Other Death (2002): Avarello TP+, N
Page 640 and 641:
(2001): Pechlaner C+, Blood Coagul
Page 642 and 643:
Bullous dermatitis (2001): Christ E
Page 644 and 645:
(1985): Schifter S+, Lancet 2, 499
Page 646 and 647:
Page 648 and 649:
VERAPAMIL Trade names: APO-Verap; A
Page 650 and 651:
Mucosal Gingival hyperplasia/hypert
Page 652 and 653:
(2001): Laack E+, Ann Oncol 12(12),
Page 654 and 655:
Fixed eruption (
Page 656 and 657:
(1986): Sjoberg A+, Lakartidningen
Page 658 and 659:
(1990): Broder S+, Am J Med 88, 31S
Page 660 and 661:
(1989): Valencia ME+, Rev Clin Esp
Page 662 and 663:
ZOLPIDEM Trade names: Ambien (Sanof
Page 664 and 665:
DRUGS RESPONSIBLE FOR COMMON REACTI
Page 666 and 667:
Ethambutol Ethanolamine Etoposide F
Page 668 and 669:
Procarbazine Progestins Promethazin
Page 670 and 671:
Erlotinib Ertapenem Escitalopram Et
Page 672 and 673:
Feverfew Floxuridine Fluconazole Fl
Page 674 and 675:
Insulin glulisine Interferon alfa I
Page 676 and 677:
Acamprosate Acebutolol Acetaminophe
Page 678 and 679:
Amobarbital Amoxicillin Amphoterici
Page 680 and 681:
Spironolactone Streptomycin Sulface
Page 682 and 683:
Miconazole Midazolam Minocycline Mi
Page 684 and 685:
Heroin Hydralazine Hydrochlorothiaz
Page 686 and 687:
Nefazodone Nevirapine Niacin Nicoti
Page 688 and 689:
Mephenytoin Mercaptopurine Mesalami
Page 690 and 691:
Cephradine Cetuximab Chamomile Chlo
Page 692 and 693:
Oxaprozin Penicillin G Phenytoin Pi
Page 694 and 695:
Ritonavir Rofecoxib Saquinavir Sele
Page 696 and 697:
Chlorotrianisene Chlorpheniramine C
Page 698 and 699:
Timolol Tinidazole Tolcapone Topira
Page 700 and 701:
Maprotiline Marihuana Mebendazole M
Page 702 and 703:
Allopurinol Alprazolam Alteplase Am
Page 704 and 705:
Azatadine Azathioprine Azithromycin
Page 706 and 707:
Phenelzine Phenindamine Phenobarbit
Page 708 and 709:
Seborrheic Dermatitis Buspirone Chl
Page 710 and 711:
Dacarbazine Dactinomycin Daptomycin
Page 712 and 713:
Anagrelide Anidulafungin Anisindion
Page 714 and 715:
Rifampin Rifapentine Rifaximin Rise
Page 716 and 717:
Tretinoin Valdecoxib Varicella vacc
Page 718:
Prazosin Pregabalin Procarbazine Pr
Page 721 and 722:
646 DESCRIPTION OF THE 34 MOST COMM
Page 723 and 724:
Page 725 and 726:
Page 728 and 729:
ALPHABETICAL INDEX Abacavir 1 Abare
Page 730 and 731:
Hawthorn (fruit, leaf, flower extra
Page 732 and 733:
Tirofiban 543 Tixocortol 543 Tizani
show all

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?